CLINICAL TRIALS PROFILE FOR DUREZOL
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
All Clinical Trials for Durezol
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT01124045 ↗ | Difluprednate Pediatric Study for the Treatment of Inflammation Post-Cataract Surgery | Completed | Alcon Research | Phase 3 | 2010-08-01 | The primary objective of this study was to compare the safety and efficacy of Durezol™ compared to Pred Forte™ for the treatment of inflammation following cataract surgery in a pediatric population 0 to 3 years of age. |
NCT01201798 ↗ | Safety and Efficacy of Difluprednate 0.05% for the Treatment of Anterior Uveitis | Completed | Alcon Research | Phase 3 | 2010-10-01 | The purpose of this study was to demonstrate that difluprednate 0.05% (Durezol) dosed 4 times daily is noninferior to prednisolone 1% (Pred Forte) dosed 8 times daily for the treatment of endogenous anterior uveitis. |
NCT01244334 ↗ | Study of Difluprednate vs. Prednisolone Acetate on Visual Acuity, and Corneal Edema Following Cataract Surgery. | Completed | Alcon Research | Phase 4 | 2009-03-01 | The purpose of this clinical research study is to investigate the efficacy of predosing patients undergoing cataract surgery with the potent corticosteroid difluprednate ophthalmic emulsion 0.05% compared to prednisolone acetate 1% on corneal edema (swelling), and retinal thickness. |
NCT01244334 ↗ | Study of Difluprednate vs. Prednisolone Acetate on Visual Acuity, and Corneal Edema Following Cataract Surgery. | Completed | Parsons Medical Communications | Phase 4 | 2009-03-01 | The purpose of this clinical research study is to investigate the efficacy of predosing patients undergoing cataract surgery with the potent corticosteroid difluprednate ophthalmic emulsion 0.05% compared to prednisolone acetate 1% on corneal edema (swelling), and retinal thickness. |
NCT01244334 ↗ | Study of Difluprednate vs. Prednisolone Acetate on Visual Acuity, and Corneal Edema Following Cataract Surgery. | Completed | Sirion Therapeutics, Inc. | Phase 4 | 2009-03-01 | The purpose of this clinical research study is to investigate the efficacy of predosing patients undergoing cataract surgery with the potent corticosteroid difluprednate ophthalmic emulsion 0.05% compared to prednisolone acetate 1% on corneal edema (swelling), and retinal thickness. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Durezol
Condition Name
Clinical Trial Locations for Durezol
Trials by Country
Clinical Trial Progress for Durezol
Clinical Trial Phase
Clinical Trial Sponsors for Durezol
Sponsor Name